AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
Amazon
AMZN
|
+$1.31B |
| 2 |
Nike
NKE
|
+$470M |
| 3 |
Visa
V
|
+$470M |
| 4 |
Etsy
ETSY
|
+$346M |
| 5 |
Gen Digital
GEN
|
+$257M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$669M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$517M |
| 3 |
Procter & Gamble
PG
|
+$388M |
| 4 |
IQVIA
IQV
|
+$299M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$298M |
Sector Composition
| 1 | Technology | 23.26% |
| 2 | Healthcare | 14.4% |
| 3 | Consumer Discretionary | 13.9% |
| 4 | Financials | 12.83% |
| 5 | Communication Services | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Cartesian Therapeutics
RNAC
$262M
| $461K | ﹤0.01% |
3,680
+947
| +35% | +$119K |
|
2827
Funko
FNKO
$182M
| $460K | ﹤0.01% |
+21,600
| New | +$460K |
|
2828
Cass Information Systems
CASS
$563M
| $459K | ﹤0.01% |
11,266
-900
| -7% | -$36.7K |
|
2829
TherapeuticsMD
TXMD
$12.5M
| $458K | ﹤0.01% |
7,695
+1,924
| +33% | +$115K |
|
2830
Central Pacific Financial
CPF
$829M
| $456K | ﹤0.01% |
17,489
-4,100
| -19% | -$107K |
|
2831
Marcus Corp
MCS
$488M
| $456K | ﹤0.01% |
21,519
-2,800
| -12% | -$59.3K |
|
2832
Bristow Group
VTOL
$1.09B
| $456K | ﹤0.01% |
17,788
+5,400
| +44% | +$138K |
|
2833
Ambac
AMBC
$424M
| $455K | ﹤0.01% |
29,030
-6,700
| -19% | -$105K |
|
2834
KALA BIO
KALA
$98.3M
| $455K | ﹤0.01% |
1,720
+869
| +102% | +$230K |
|
2835
Kiniksa Pharmaceuticals
KNSA
$2.73B
| $454K | ﹤0.01% |
32,600
+10,600
| +48% | +$148K |
|
2836
Boston Omaha
BOC
$421M
| $453K | ﹤0.01% |
14,300
-1,600
| -10% | -$50.7K |
|
2837
Harmonic Inc
HLIT
$1.13B
| $451K | ﹤0.01% |
52,969
-50
| -0.1% | -$426 |
|
2838
ESSA Pharma
EPIX
$11.4M
| $450K | ﹤0.01% |
+15,745
| New | +$450K |
|
|
NESR
2839
National Energy Services Reunited Corp. Ordinary Shares
NESR
$973M
| $450K | ﹤0.01% |
31,600
+6,500
| +26% | +$92.6K |
|
|
XOG
2840
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
| $450K | ﹤0.01% |
+8,200
| New | +$450K |
|
2841
Gossamer Bio
GOSS
$630M
| $449K | ﹤0.01% |
55,300
-81,322
| -60% | -$660K |
|
|
CTV
2842
DELISTED
Innovid Corp.
CTV
| $449K | ﹤0.01% |
+45,439
| New | +$449K |
|
|
FFNW
2843
DELISTED
First Financial Northwest, Inc
FFNW
| $448K | ﹤0.01% |
+29,557
| New | +$448K |
|
|
TCRR
2844
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $448K | ﹤0.01% |
27,300
+6,600
| +32% | +$108K |
|
2845
HCI Group
HCI
$2.26B
| $447K | ﹤0.01% |
4,500
-1,300
| -22% | -$129K |
|
|
KDNY
2846
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $446K | ﹤0.01% |
31,620
+7,400
| +31% | +$104K |
|
2847
Altimmune
ALT
$334M
| $446K | ﹤0.01% |
+45,300
| New | +$446K |
|
2848
SIGA Technologies
SIGA
$627M
| $443K | ﹤0.01% |
70,600
+6,000
| +9% | +$37.6K |
|
|
GBL
2849
DELISTED
GAMCO Investors, Inc.
GBL
| $443K | ﹤0.01% |
17,653
-2,000
| -10% | -$50.2K |
|
2850
BlackRock MuniHoldings Fund
MHD
$598M
| $442K | ﹤0.01% |
26,351
| – | – |
|